The selection of point mutation at codon 164 (from isoleucine to leucine) of the dihydrofolate reductase (DHFR) enzyme in Plasmodium falciparum is associated with high sulfadoxine /pyrimethamine (SP) resistance. Using the yeast expression system that allows the detection of dhfr allele present at low level, the presence of this mutation had previously been reported between 1998-1999 in Muheza, Tanzania, an area of high SP resistance. Eighty five P. falciparum isolates, obtained from the same area between 2002 and 2003, were analysed for the presence of Leu-164 mutation, using standard protocol based on PCR-RFLP. None of the isolates had the Leu-164 mutation
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Mutations in the dihydrofolate reductase gene (dhfr) of Plasmodium falciparum have been proposed as ...
The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a ...
The selection of point mutation at codon 164 (from isoleucine to leucine) of the dihydrofolate reduc...
Abstract. Point mutations in the genes for dihydrofolate reductase (DHFR) and dihydropteroate syntha...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
Abstract. Sulfadoxine-pyrimethamine (SP) is the second-line treatment for Plasmodium falciparum mala...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
Abstract. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine (S/P) is due to mutations in...
Abstract. Standard polymerase chain reaction methods often cannot detect drug-resistance mutations i...
Resistance to the antifolate sulfadoxine-pyrimethamine (SP), the current mass-treatment antimalarial...
Abstract. The present study was designed to characterize mutations in dihydrofolate reductase (DHFR)...
The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a ...
Abstract. Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic ...
International audienceMolecular investigations performed following the emergence of sulfadoxine-pyri...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Mutations in the dihydrofolate reductase gene (dhfr) of Plasmodium falciparum have been proposed as ...
The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a ...
The selection of point mutation at codon 164 (from isoleucine to leucine) of the dihydrofolate reduc...
Abstract. Point mutations in the genes for dihydrofolate reductase (DHFR) and dihydropteroate syntha...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
Abstract. Sulfadoxine-pyrimethamine (SP) is the second-line treatment for Plasmodium falciparum mala...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
Abstract. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine (S/P) is due to mutations in...
Abstract. Standard polymerase chain reaction methods often cannot detect drug-resistance mutations i...
Resistance to the antifolate sulfadoxine-pyrimethamine (SP), the current mass-treatment antimalarial...
Abstract. The present study was designed to characterize mutations in dihydrofolate reductase (DHFR)...
The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a ...
Abstract. Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic ...
International audienceMolecular investigations performed following the emergence of sulfadoxine-pyri...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Mutations in the dihydrofolate reductase gene (dhfr) of Plasmodium falciparum have been proposed as ...
The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a ...